Empowering Patients in the Value Debate
Patients need a more meaningful role in decisions about the value of medications, a new report from the Global Alliance for Patient Access explains.
Arthritis & the European Workforce
Effectively treating rheumatic and musculoskeletal diseases doesn’t just serve patients. It also benefits Europe’s workplaces.
European Patient Groups Call for HTA Improvements
The COVID-19 pandemic has made one point clear for advocates: Health technology assessments across Europe could work better and more efficiently.
Cardiovascular Advocates Elevate Global Call to Action
Reaching consensus is a challenge for any community, and the global health care community is no exception.
Non-Communicable Disease Treatment Falters Under COVID-19
According to new research from the World Health Organization, the treatment and prevention of non-communicable diseases have been “severely disrupted” since the pandemic began.
Neurological Patient Groups Tackle COVID-19 Challenges
Last month patient groups and Members of the European Parliament pledged to “leave no-one behind” in their response to the COVID-19 pandemic.
Why Heart Patients Should #JustGo
“COVID phobia” has increased the novel coronavirus’ collateral damage by stopping high-risk patients from seeking necessary care.
Addressing Rheumatic & Musculoskeletal Diseases During COVID-19
With the world’s attention on new and re-emerging outbreaks of COVID-19, advocates are working towards policies that ensure care for overshadowed patient groups.
The Forgotten COVID-19 Vulnerability
As the COVID-19 crisis grows, policymakers may be overlooking a vulnerable population: patients living with rheumatic and musculoskeletal diseases like rheumatoid arthritis.
Advocates Unite on Access to Neurological Care
A new report spotlights the need for patient-centred neurological care across the globe.
